1. Latest Updates on Lipid Management.
- Author
-
Egom EE, Pharithi RB, Hesse S, Starr N, Armstrong R, Sulaiman HM, Gazdikova K, Mozos I, Caprnda M, Kubatka P, Kruzliak P, Khan B, Gaspar L, and Maher VMG
- Subjects
- Anticholesteremic Agents adverse effects, Atherosclerosis blood, Atherosclerosis diagnosis, Atherosclerosis mortality, Biomarkers blood, Diet, Healthy, Dyslipidemias blood, Dyslipidemias diagnosis, Dyslipidemias mortality, Exercise, Humans, Protective Factors, Risk Factors, Risk Reduction Behavior, Treatment Outcome, Anticholesteremic Agents therapeutic use, Atherosclerosis drug therapy, Cholesterol blood, Dyslipidemias drug therapy, Triglycerides blood
- Abstract
Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death worldwide. Despite the clinical long-term and near-term benefits of lowering cholesterol in, respectively, primary and secondary prevention of ASCVD, cholesterol levels remain under-treated, with many patients not achieving their recommended targets. The present article will review the latest updates on lipid management with emphases on the different classes of cholesterol-lowering agents and their clinical uses.
- Published
- 2019
- Full Text
- View/download PDF